The opioid system consists of endogenous opioid peptides (endorphins, enkephalins, dynorphins) and their receptors (mu, delta, kappa) that modulate pain, reward, stress responses, mood, and immune function. This system is evolutionarily ancient, regulating analgesia, social bonding, and homeostatic stress responses.
Endogenous opioids (beta-endorphin from POMC, enkephalins from proenkephalin, dynorphins from prodynorphin) bind to opioid receptors: (1) Mu opioid receptors (MOR) — analgesia, reward, euphoria; (2) Delta opioid receptors (DOR) — analgesia, antidepressant effects; (3) Kappa opioid receptors (KOR) — dysphoria, stress responses, aversion. Opioids inhibit nociceptive transmission in the spinal cord (dorsal horn), activate descending pain inhibition from PAG and RVM, and modulate emotional pain in limbic structures. In freeze response (totstell reflex), massive opioid release produces analgesia and dissociation. The opioid system is also critical for enteric nervous system development in utero. Chronic stress or exogenous opioid use leads to tolerance and receptor desensitization.
The endogenous opioid system is central to pain modulation, stress resilience, and emotional regulation. Dysfunction occurs in: (1) Chronic pain — opioid tolerance and descending facilitation replace inhibition; (2) Trauma/PTSD — freeze response causes persistent opioid dysregulation; (3) Addiction — exogenous opioids hijack reward pathways leading to tolerance; (4) Depression — low endogenous opioid tone contributes to anhedonia; (5) IBS and gut disorders — opioid system development in ENS is disrupted by early-life stress. Therapeutic approaches include: enhancing endogenous opioid release (exercise, social connection, laughter), low-dose naltrexone (LDN) to upregulate receptors, and addressing trauma underlying opioid dysregulation.
- Three main receptor types: mu (MOR), delta (DOR), kappa (KOR)
- Endogenous ligands: beta-endorphin, enkephalins, dynorphins
- MOR activation produces analgesia, reward, and respiratory depression
- KOR activation produces dysphoria and stress responses
- Massive opioid release during freeze/totstell response causes analgesia and dissociation
- Required for proper enteric nervous system development in embryo/early life
- Chronic stress or opioid use leads to tolerance and receptor desensitization
- Low-dose naltrexone (LDN) can upregulate opioid receptors
- beta-endorphin — primary endogenous opioid peptide binding to mu receptors
- enkephalins — endogenous opioid peptides with delta/mu receptor affinity
- pain modulation — opioids are primary endogenous pain-modulating molecules
- PAG — PAG opioid neurons activate descending pain inhibition
- RVM — rostral ventromedial medulla receives opioid signals from PAG
- freeze response — freeze response triggers massive opioid release causing analgesia
- dissociation — opioid surge during trauma produces dissociative states
- PTSD — trauma-induced opioid dysregulation contributes to PTSD symptoms
- chronic pain — opioid tolerance develops in chronic pain reducing endogenous analgesia
- reward system — mu opioid activation in VTA/nucleus accumbens mediates reward
- addiction — exogenous opioids hijack reward pathways causing addiction
- enteric nervous system — opioid signaling required for ENS development in utero
- IBS — disrupted opioid signaling in ENS contributes to IBS
- locus coeruleus — opioid tolerance in LC changes stress response patterns
- social bonding — endogenous opioids mediate social bonding and attachment
- exercise — exercise increases endogenous opioid release (runner's high)
- low-dose naltrexone — LDN blocks opioid receptors briefly causing compensatory upregulation
- morphine — exogenous opioid that mimics endogenous opioid action
- tolerance — chronic opioid exposure leads to receptor desensitization and tolerance
- anhedonia — low endogenous opioid tone contributes to anhedonia in depression